Broadview Ventures is a venture capital firm based in Boston, Massachusetts. The firm invests in companies operating in the small molecules, biologics, genetic medicines, cell, gene therapies, implantable, interventional, remote monitoring devices, stand-alone or companion diagnostics, including in vitro, imaging and digital technologies sectors based in North America, Europe and Israel. The firm's primary investment goal is to improve human health in the areas of cardiovascular disease and stroke.